z-logo
open-access-imgOpen Access
Pharmacotherapy Review: Angiotensin‐Converting Enzyme Inhibitors
Author(s) -
Sica Domenic A.
Publication year - 2005
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/j.1524-6175.2005.04125.x
Subject(s) - medicine , pharmacotherapy , drug class , drug , selection (genetic algorithm) , intensive care medicine , pharmacology , artificial intelligence , computer science
On inspection of most treatment algorithms for hypertension, it is apparent that multiple drug classes are available. In choosing a medication class for hypertension therapy, nuances of the selection process often go unappreciated. This article is the first in a series describing important pharmacotherapeutic considerations of the individual drug classes used in the treatment of hypertension.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here